| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/12/1993 | EP0540604A1 Substituted bicyclic bis-aryl compounds exhibiting selective leukotriene b 4? antagonist activity, their preparation and use in pharmaceutical compositions |
| 05/12/1993 | EP0525054A4 Modified heparin binding growth factors |
| 05/12/1993 | CN1071930A Inhibitors of hiv protease useful for treatment of aids |
| 05/12/1993 | CN1071928A Rhenium and technetium complexes containing hypoxia-localizing moiety |
| 05/12/1993 | CN1020605C Process for preparing azacycloparaffin derivatives |
| 05/12/1993 | CA2082450A1 Hybrid transforming growth factors |
| 05/11/1993 | US5210208 Disubstituted aryl compounds exhibiting selective leukotriene b4 antagonist activity |
| 05/11/1993 | US5210092 Hypotensive agents |
| 05/11/1993 | US5210082 Treating panic disorder |
| 05/11/1993 | US5210076 Methods of treating Parkinson's disease using melanin |
| 05/11/1993 | US5210017 Ligand-mediated immunofunctional hormone binding protein assay method |
| 05/11/1993 | CA1317587C Esters |
| 05/11/1993 | CA1317545C Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs |
| 05/08/1993 | CA2082216A1 Polycyclic conjugates |
| 05/05/1993 | EP0540421A1 Indigestible dextrin |
| 05/05/1993 | EP0540400A1 Quinoline derivatives, useful as angiotensin II antagonists |
| 05/05/1993 | EP0540356A2 Process for the preparation of certain substituted biphenyl tetrazoles and compounds thereof |
| 05/05/1993 | EP0540165A1 Alkanoic acid derivatives |
| 05/05/1993 | EP0540099A1 Water soluble camptothecin derivatives |
| 05/05/1993 | EP0540051A1 Aromatic amidine derivatives and salts thereof |
| 05/05/1993 | EP0539848A1 N-(mercaptoacyl)amino acids, methods of their preparation and therapeutic use, and pharmaceutical compositions containing them |
| 05/05/1993 | EP0539806A1 Thiadiazinones and medicines containing them, having in particular a positive inotropic and vasodilating activity |
| 05/05/1993 | EP0539803A1 Triazospirodecanone-methyl-chromans for the treatment of central nervous system illnesses |
| 05/05/1993 | EP0539591A1 Benzodiazepine derivatives |
| 05/05/1993 | EP0539527A1 Analogs of carbonic anhydrase inhibitors and their use as topical iop inhibitors |
| 05/05/1993 | EP0539525A1 Vitaletheine and use in cell culture and therapy |
| 05/05/1993 | EP0539442A1 Enzyme inactivators |
| 05/05/1993 | EP0539421A1 Novel oxazolyl derivatives |
| 05/05/1993 | EP0539420A1 Novel substituted thiazolyl and substituted pyridinyl derivatives |
| 05/05/1993 | EP0515569A4 Calcium channel compositions and methods |
| 05/05/1993 | EP0289584B1 Wound healing and bone regeneration |
| 05/05/1993 | EP0211077B1 Metalloproteinase inhibitor sequence recombinant vector system for using same and recombinant-dna method for the manufacture of same |
| 05/05/1993 | CN1020458C Conjugates of superoxide dismutase couples tod high molecular weight polyalkylene glycols |
| 05/05/1993 | CA2081808A1 Combination of calcium antagonists with cholinesterase inhibitors |
| 05/04/1993 | US5208259 Diaryl ether hetrocycles |
| 05/04/1993 | US5208255 Thioester enantiomeric compounds and their therapeutic uses |
| 05/04/1993 | US5208251 Compounds for antiinflammatory agents, antiallergens, antiarthritic, antiulcer agents |
| 05/04/1993 | US5208249 Method for stimulating intracellular synthesis of glutathione using esters of L-2-oxothiazolidine-4-carboxylate |
| 05/04/1993 | US5208240 8-substituted purines as selective adenosine receptor agents |
| 05/04/1993 | US5208041 Essentially pure human parathyroid hormone |
| 05/02/1993 | CA2081847A1 Process for the preparation of certain substituted biphenyl tetrazoles and compounds thereof |
| 04/30/1993 | CA2081580A1 Water soluble camptothecin derivatives |
| 04/29/1993 | WO1993008267A1 Cell cycle controlling compositions and methods of using same |
| 04/29/1993 | WO1993008207A1 Novel cytokine |
| 04/29/1993 | WO1993008197A1 Thienopyrazine-2,3-diones and their preparation and use |
| 04/29/1993 | WO1993008192A1 Azabicyclo arylacetylene and arylenyne oximes as cholinergic agents and methods of treatment |
| 04/29/1993 | WO1993008188A1 Tricyclic quinoxalinediones as glutamate receptor antagonists |
| 04/29/1993 | WO1993008187A1 Imidazopyridines and indolizines as 5-ht4 antagonists |
| 04/29/1993 | WO1993008184A1 Hiv protease inhibitors |
| 04/29/1993 | WO1993008174A1 NONPEPTIDYL INTEGRIN INHIBITORS HAVING SPECIFICITY FOR THE GPIIbIIIa RECEPTOR |
| 04/29/1993 | WO1993008169A1 Substituted aminopyrimidines as angiotensine ii antagonists |
| 04/29/1993 | WO1993008162A1 N-(mercaptoacyl)amino acids, methods of their preparation and therapeutic use, and pharmaceutical compositions containing them |
| 04/29/1993 | CA2121845A1 Heterocyclic compounds and their preparations and use |
| 04/29/1993 | CA2121815A1 Substituted aminopyrimidines as angiotensine ii antagonists |
| 04/29/1993 | CA2121801A1 N-(mercaptoacyl)amino acids, methods of their preparation and therapeutic use, and pharmaceutical compositions containing them |
| 04/29/1993 | CA2120915A1 Tricyclic quinoxalinediones |
| 04/29/1993 | CA2081537A1 Quinoline derivatives, process for their preparation, and their therapeutic applications |
| 04/29/1993 | CA2081300A1 2-aminomethyl-chromans |
| 04/29/1993 | CA2081256A1 Triazaspirodecanone-methylchromans |
| 04/28/1993 | EP0539192A1 HIV Protease inhibitors |
| 04/28/1993 | EP0539167A2 Peg imidates and protein derivatives thereof |
| 04/28/1993 | EP0539117A1 Compounds useful as leukotriene antagonists |
| 04/28/1993 | EP0539087A1 Stabilized topical acidic fibroblast growth factor formulation |
| 04/28/1993 | EP0539066A1 Heterocyclic compounds useful as angiotensin II antagonists |
| 04/28/1993 | EP0538404A1 Fibroblast growth factor receptors |
| 04/28/1993 | EP0538399A1 Cyclic cell adhesion modulation compounds |
| 04/28/1993 | EP0538383A1 Inhibitors of aspartic proteases |
| 04/28/1993 | EP0538330A1 Beta-alethine use in cell culture and therapy. |
| 04/28/1993 | EP0538262A1 N-dimethoxy phenyl alkyl-n'-imidazolyl phenyl amidine derivatives and process thereof |
| 04/28/1993 | EP0499625A4 Conglutinin fragments, their production and use |
| 04/28/1993 | EP0453456B1 Pdgf-a, pdgf-aa, pdgf-ab, process for producing them and drugs containing them |
| 04/28/1993 | CN1071426A Process for the preparation of novel acylals of imidazole-5-carboxylic acid derivatives |
| 04/28/1993 | CN1071418A Benzo (f) quinolinones |
| 04/28/1993 | CN1071333A Calcium receptor active molecules |
| 04/27/1993 | US5206384 Actinonin derivatives and pharmaceutically acceptable salts thereof |
| 04/27/1993 | US5206373 Process for preparing fibrinogen receptor antagonists |
| 04/27/1993 | US5206255 Heterocyclic compound |
| 04/27/1993 | US5206239 Pyrroloazepine derivatives |
| 04/27/1993 | US5206235 Animal growth regulators; stimulants |
| 04/27/1993 | US5206023 Method and compositions for the treatment and repair of defects or lesions in cartilage |
| 04/27/1993 | US5206008 Using androstene(diol or triol) |
| 04/27/1993 | CA1317069C2 Synthetic peptides having pituitary growth hormone releasing activity |
| 04/27/1993 | CA1316932C Methods and compositions for inhibiting lipoxygenase |
| 04/27/1993 | CA1316928C Alpha-heterocycle substituted tolunitriles |
| 04/27/1993 | CA1316927C Antihypercholesterolemic beta-lactones |
| 04/27/1993 | CA1316832C Treatment of human viral infection by dsrna combined with viral inhibitors |
| 04/27/1993 | CA1316828C Compounds having anti-metastatic and/or anti-inflammatory activity |
| 04/27/1993 | CA1316649C Moulding contact lenses |
| 04/25/1993 | CA2081133A1 Pharmaceutical compounds |
| 04/24/1993 | CA2081134A1 Hiv protease inhibitors |
| 04/24/1993 | CA2081049A1 Thiadiazinones |
| 04/22/1993 | CA2080891A1 Peg imidates and protein derivatives thereof |
| 04/22/1993 | CA2080537A1 Stabilized topical acidic fibroblast growth factor formulation |
| 04/21/1993 | EP0538192A1 New 17-beta-substituted aza-androstanderivatives |
| 04/21/1993 | EP0538134A2 Mono-fluorinated derivatives of N-propargyl-1-aminoindan and their use as inhibitors of monoamine oxidase |
| 04/21/1993 | EP0538016A1 MRSA active 2-phenyl-carbapenems |
| 04/21/1993 | EP0538001A1 MRSA active 2-halophenyl carbapenems |
| 04/21/1993 | EP0537937A2 Substituted pyrazino 2,3-D pyrimidinones as angiotensin II antagonists |
| 04/21/1993 | EP0537166A1 Water-soluble polypeptides having high affinity for interferons alpha and beta |
| 04/21/1993 | EP0490919A4 Cytoprotective fatty moiety compounds |